Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

488
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
Hazard Ratio01:12

Hazard Ratio

641
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
641
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

27
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
27
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

545
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
545
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

388
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
388

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimation of Physiological Metrics from Resting ECGs Using Deep Learning in the UK Biobank, Including submaximal exercise derived V̇O <sub>2</sub> max, Body Fat Percentage, and Grip Strength.

medRxiv : the preprint server for health sciences·2026
Same author

Prediction of Left Atrial Volume Parameters from Resting ECGs and Tabular Data Using Deep Learning in the UK Biobank.

medRxiv : the preprint server for health sciences·2026
Same author

AI-Detected Asymptomatic Atrial Fibrillation and Risk of Incident Ischemic Stroke and Cardiovascular Events: A UK Biobank Study.

medRxiv : the preprint server for health sciences·2026
Same author

Biomarkers for Atherosclerotic Cardiovascular Events in Rheumatoid Arthritis: Towards Validation of a Biomarker-Enhanced Risk Model.

medRxiv : the preprint server for health sciences·2026
Same author

Development and validation of a clinical risk prediction rule to identify inflammatory arthritis at the point of rheumatology triage.

Rheumatology advances in practice·2026
Same author

Unsupervised Learning Analysis of Triglycerides, Inflammation, Cholesterol, and the Risks of Incident Cardiovascular Disease and Type 2 Diabetes in the Women's Health Study.

Journal of the American Heart Association·2025

Related Experiment Video

Updated: Feb 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Clinical risk reclassification at 10 years.

Nancy R Cook1, Olga V Demler1, Nina P Paynter1

  • 1Harvard Medical School, Brigham & Women's Hospital, Boston, MA, 02215, U.S.A.

Statistics in Medicine
|November 21, 2017
PubMed
Summary

Calibration significantly impacts model fit statistics like net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Understanding how event rates affect these measures is crucial for accurate clinical use and model assessment.

Keywords:
calibrationclinical utilityreclassification

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

942

Related Experiment Videos

Last Updated: Feb 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

942

Area of Science:

  • Biostatistics
  • Medical Statistics
  • Health Informatics

Background:

  • Model fit statistics are essential for evaluating diagnostic and prognostic models.
  • Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) are widely used measures.
  • The influence of calibration on these statistics requires careful consideration.

Purpose of the Study:

  • To review the development and understanding of reclassification statistics.
  • To examine the impact of event rates on NRI and IDI.
  • To discuss the role and assessment of calibration in statistical models.

Main Methods:

  • Theoretical analysis of NRI and IDI with varying event rates.
  • Application of theoretical findings to an example dataset.
  • Review of calibration assessment methods.

Main Results:

  • The two-category NRI and IDI are demonstrably affected by changes in the event rate.
  • Calibration plays a critical role in the performance of reclassification statistics.
  • The event rate NRI has specific relevance for clinical applications.

Conclusions:

  • Accurate calibration is fundamental for reliable model fit statistics.
  • Understanding event rate effects on NRI and IDI enhances their appropriate use.
  • The findings provide guidance for the clinical interpretation of reclassification measures.